Project Grant HT94252410014
Award Date 8/1/24
Completion Date 7/31/26
Dollars Obligated $297K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Birmingham, AL 35294, USA
Similar Awards
- The University of Alabama at Birmingham (UAB) was awarded a $1,485,000.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to improve the oncolytic immunovirotherapy of malignant glioma by targeting the glioma secretome. The 3-year grant was awarded on September 30, 2023 and is set to conclude on September 29, 2026. UAB is a public research university known for its innovative and interdisciplinary approach to education, and it...
- The University of Alabama at Birmingham (UAB) was awarded a $733,662 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on September 1, 2024, supports research to investigate the role of tumor glycans in immune suppression. This federally funded project aims to advance scientific understanding of how specific carbohydrate molecules on tumor cells can inhibit the body's immune response, with the goal of...
- The University of Alabama at Birmingham (UAB) was awarded a $1,485,001 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on March 1, 2025, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research project, titled "Overcoming Perturbations that Orchestrate Immune Exhaustion and Dysfunction in Breast Cancer,"...
- The University of Alabama at Birmingham (UAB) received a $1,599,981.00 Project Grant award from the Defense Health Agency on June 1, 2024 under the Military Medical Research and Development program (CFDA 12.420). The grant supports research to activate immune reserves and prevent secondary bacterial lung infections after trauma and hemorrhage. This biomedical research project aims to improve health outcomes for military service members and the broader public. The project will be conducted over a...
- The University of Alabama at Birmingham (UAB) was awarded a $2,069,849 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The award will support UAB's research from May 1, 2023 to April 30, 2027 to understand cardiovascular disease in mental health and stress disorders. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical research,...
- The University of Alabama at Birmingham (UAB) was awarded a $220,326 project grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to develop novel, selective PARP protein degraders for prostate cancer treatment utilizing PSMA uptake enhancement. The award period runs from April 1, 2025 to March 31, 2027. This grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public...
- The University of Alabama at Birmingham (UAB) received a $724,115 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The purpose of this 3-year grant, awarded on September 1, 2024, is to conduct research on the utility of sodium nitrite in improving recovery after spinal cord injuries. As a leading research institution, UAB will leverage its expertise in biomedical engineering, neuroscience, and clinical trials to...
- The University of Alabama at Birmingham (UAB) has been awarded a $740,075 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to conduct research on "PADI4 as a Driver and Therapeutic Target for Uveal Melanoma Therapy". The award, which runs from September 1, 2024 to August 31, 2027, will support UAB's research into novel therapeutic approaches for treating uveal melanoma, an aggressive form of eye cancer. As a leading research...
- Federal Grant Award Summary The University of Alabama at Birmingham received a $148,500 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), effective October 1, 2025 through September 30, 2026. The award supports research investigating the polyol pathway's role in promoting renal cancer tumorigenesis via glucose-mediated lipogenesis. This biomedical research project contributes to the Defense Health Agency's mission of...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $723,948.00 to the University of Alabama at Birmingham (UAB) to study the role of adaptive immune activation in solvent-induced Parkinson's neurodegeneration. The project will be conducted over the period of Aug 1, 2023 to Jul 31, 2026. UAB is a public research university known for its innovative and interdisciplinary approach to education, and has...